Polygenic Risk Score Combined with Transcranial Sonography Refines Parkinson's Disease Risk Prediction

被引:0
|
作者
Kals, Mart [1 ]
Reigo, Anu [1 ]
Teder-Laving, Maris [1 ]
Vaht, Mariliis [1 ]
Nikopensius, Tiit [1 ]
Metspalu, Andres [1 ,2 ]
Toomsoo, Toomas [3 ,4 ]
机构
[1] Univ Tartu, Inst Genom, Estonian Genome Ctr, Tartu, Estonia
[2] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia
[3] Confido Med Ctr, Veerenni 51, EE-10138 Tallinn, Estonia
[4] Tallinn Univ, Sch Nat Sci & Hlth, Tallinn, Estonia
关键词
Parkinson's disease; polygenic risk score; substantia nigra hyperechogenicity; transcranial sonography; SUBSTANTIA-NIGRA HYPERECHOGENICITY; RESEARCH CRITERIA; IDENTIFICATION; METAANALYSIS; ASSOCIATION; DISORDER; MIDBRAIN; FEATURES; MARKERS; SIGNS;
D O I
10.1002/mdc3.70011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Dopaminergic neuron depletion in the substantia nigra (SN) and the pathological aggregation of alpha-synuclein are the neuropathological hallmarks of Parkinson's disease (PD). Objectives : This study aimed to investigate the association between the polygenic risk score for PD (PD-PRS) and transcranial sonography (TCS)-measured SN hyperechogenicity to enhance the accuracy of PD susceptibility prediction. Methods : PD-PRSs were calculated for over 41,000 Estonian Biobank participants age 55+ years without a PD diagnosis. Participants in the highest and lowest PD-PRS percentiles (n = 222) underwent TCS measurements and Sniffin' sticks olfactory testing. A multivariable logistic regression model was used to examine the associations between PD-PRS, risk and prodromal markers, and SN hyperechogenicity. Results : Data from 204 participants with TCS measurements were analyzed, including 107 individuals in the high-risk PD-PRS group and 97 in the low-risk PD-PRS group. Incorporating PD-PRS group assignment improved the explained variance in SN hyperechogenicity from 17.2% to 31.9%. Participants in the low-risk PD-PRS group had 0.16 times lower odds (95% confidence interval (CI) = 0.07-0.35, P < 0.001) of developing SN hyperechogenicity compared to high-risk PD-PRS individuals. Each unit increase in the Sniffin' sticks olfactory test score was significantly associated with reduced odds of SN hyperechogenicity (adjusted odds ratio = 0.60, 95% CI = 0.47-0.78, P = 0.002). Conclusions : Our findings indicate that TCS-measured SN hyperechogenicity is associated with PD-PRS and olfactory impairment. This combined assessment may improve early diagnosis of prodromal PD by pinpointing individuals at increased risk.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Integration of risk factor polygenic risk score with disease polygenic risk score for disease prediction
    Jung, Hyein
    Jung, Hae-Un
    Baek, Eun Ju
    Kwon, Shin Young
    Kang, Ji-One
    Lim, Ji Eun
    Oh, Bermseok
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [2] Integration of risk factor polygenic risk score with disease polygenic risk score for disease prediction
    Hyein Jung
    Hae-Un Jung
    Eun Ju Baek
    Shin Young Kwon
    Ji-One Kang
    Ji Eun Lim
    Bermseok Oh
    Communications Biology, 7
  • [3] Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease
    Blauwendraat, Cornelis
    Tayebi, Nahid
    Woo, Elizabeth Geena
    Lopez, Grisel
    Fierro, Luca
    Toffoli, Marco
    Limbachiya, Naomi
    Hughes, Derralynn
    Pitz, Vanessa
    Patel, Dhairya
    Vitale, Dan
    Koretsky, Mathew J.
    Hernandez, Dena
    Real, Raquel
    Alcalay, Roy N.
    Nalls, Mike A.
    Morris, Huw R.
    Schapira, Anthony H. V.
    Balwani, Manisha
    Sidransky, Ellen
    MOVEMENT DISORDERS, 2023, 38 (05) : 899 - 903
  • [4] Validity and Prognostic Value of a Polygenic Risk Score for Parkinson's Disease
    Koch, Sebastian
    Laabs, Bjoern-Hergen
    Kasten, Meike
    Vollstedt, Eva-Juliane
    Becktepe, Jos
    Brueggemann, Norbert
    Franke, Andre
    Kraemer, Ulrike M.
    Kuhlenbaeumer, Gregor
    Lieb, Wolfgang
    Mollenhauer, Brit
    Neis, Miriam
    Trenkwalder, Claudia
    Schaeffer, Eva
    Usnich, Tatiana
    Wittig, Michael
    Klein, Christine
    Koenig, Inke R.
    Lohmann, Katja
    Krawczak, Michael
    Caliebe, Amke
    GENES, 2021, 12 (12)
  • [5] Joint effects of rare GBA variants and polygenic risk score on Parkinson's disease risk
    Landoulsi, Zied
    Pachchek, Sinthuja P.
    Bobbili, Dheeraj
    Kruger, Rejko
    May, Patrick
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 491 - 491
  • [6] Mitochondrial-specific polygenic risk score is associated with increased Parkinson's disease risk
    Landoulsi, Z.
    Bobbili, D.
    Pachcheck, S.
    Arena, G.
    Kruger, R.
    May, P.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 410 - 410
  • [7] Validation and Assessment of Predictive Ability for a Polygenic Risk Score on Parkinson's Disease
    Koch, Sebastian
    Laabs, Bjoen-Hergen
    Kasten, Meike
    Vollstedt, Eva-Juliane
    Klein, Christine
    Koenig, Inke R.
    Lohmann, Katja
    Krawczak, Michael
    Caliebe, Amke
    GENETIC EPIDEMIOLOGY, 2022, 46 (07) : 506 - 506
  • [8] Validation and assessment of predictive ability for a Polygenic Risk Score on Parkinson's disease
    Koch, Sebastian
    Caliebe, Amke
    Krawczak, Michael
    HUMAN HEREDITY, 2022, VOL. (SUPPL 1) : 12 - 12
  • [9] Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson's Disease Risk
    Han, Yingnan
    Teeple, Erin
    Shankara, Srinivas
    Sadeghi, Mahdiar
    Zhu, Cheng
    Liu, Dongyu
    Wang, Clarence
    Frau, Francesca
    Klinger, Katherine
    Madden, Stephen
    Rajpal, Deepak
    Sardi, Pablo
    Kumar, Dinesh
    NEUROLOGY, 2021, 96 (15)
  • [10] Transcranial sonography in Parkinson's disease
    Fedotova, E. Yu.
    Chechetkin, A. O.
    Shadrina, M. I.
    Slominsky, P. A.
    Ivanova-Smolenskaya, I. A.
    Illarioshkin, S. N.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (01) : 49 - 55